RWD92 Adherence Advantages of Long-Acting Injectable Antipsychotics (LAIS) in Schizophrenia. Is the Currently Available Real-World Evidence Adequate or Conclusive?
- Resource Type
- Abstract
- Source
- In
Value in Health July 2022 25(7) Supplement:S593-S594 - Subject
- Language
- ISSN
- 1098-3015